| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | NEUTRAL | NEUTRAL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | N/A | N/A | N/A | N/A | N/A |
| MA10 | N/A | N/A | N/A | N/A | N/A |
| MA20 | N/A | N/A | N/A | N/A | N/A |
| MA50 | N/A | N/A | N/A | N/A | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | N/A | N/A |
| RSI | N/A | N/A | N/A | N/A | N/A |
| STOCH | N/A | N/A | N/A | N/A | N/A |
| WILL %R | N/A | N/A | N/A | N/A | N/A |
| CCI | N/A | N/A | N/A | N/A | N/A |
|
Wednesday, October 15, 2025 07:17 AM
Biotechnology company bioAffinity Technologies (NASDAQ:BIAF) said on Wednesday that it has regained compliance with Nasdaq's all applicable continued listing requirements. In a letter dated October 14 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/11/25 | 25.44 | 25.559 | 25.4249 | 25.465 | 6,800 |
| 12/11/25 | 25.515 | 25.53 | 25.496 | 25.496 | 4,300 |
| 11/11/25 | 25.52 | 25.63 | 25.515 | 25.55 | 79,500 |
|
|
||||
|
|
||||
|
|